The US is resuming its rollout of Johnson & Johnson's vaccine after a pause to investigate blood clots
The COVID-19 shot will now come with a warning about rare blood clots occurring in women under 50.
Full Article
The US is resuming its rollout of Johnson & Johnson's vaccine after a pause to investigate blood clots
Business Insider
0 shares
1 views
You might like
Related news coverage
Health Officials Push Johnson & Johnson Vaccine Confidence
Newsy
Watch VideoSince the vaccine rollout started, we've been talking about public trust and confidence in the vaccines.
Now..
Advertisement
More coverage
US Lifts Pause on Johnson & Johnson COVID-19 Vaccine but Warns Increased Risk of Rare Blood Clots
HNGN
The Johnson & Johnson COVID-19 vaccine would be used again in the United States, the CDC and the FDA announced Friday following an..